Citations

Showing 10 of 108081 citations.

Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy
Jin, Zhongbo , Fan, Wei , Jensen, Mark A, Dorschner, Jessica M., Bonadurer, George F., Vsetecka, Danielle, Amin, Shreyasee , Makol, Ashima , Ernste, Floranne C. , Osborn, Thomas G. , Moder, Kevin G., Chowdhary, Vaidehi , Niewold, Timothy B. , Jensen, Mark A. , Vsetecka, Danielle M, Ernste, Floranne, Osborn, Thomas, Moder, Kevin, Jensen, Mark A, Makol, Ashima

Mayo Clinic

Lupus Science & Medicine | June 26, 2017 | Volume: 4 | Issue: 1 | Pages: e000202

10.1136/lupus-2016-000202 | PMID 29238602 Get It

Objectives Important findings can be masked in gene expression studies of mixed cell populations. We examined single-cell gene expression in SLE patient monocytes in the context of clinical and immunological features. Methods Monocytes were purified from patients with SLE and controls, and individually isolated for single-cell gene expression measurement. A panel of monocyte-related transcripts were measured in individual classical (CL) and non-classical (NCL) monocytes. Results Analyses of both CL and NCL monocytes demonstrated that many genes had a lower expression rate in SLE monocytes than in controls. Unsupervised hierarchical clustering of the CL and NCL data sets demonstrated independent clusters of cells from the patients with SLE that were related to disease activity, type I interferon (IFN) and medication use. Thus, each of these factors exerted a different impact on monocyte gene expression that could be identified separately, and a number of genes correlated uniquely with disease activity. We found within-cell correlations between genes directly induced by type I IFN-induced and other non–IFN-induced genes, suggesting the downstream biological effects of type I IFN in individual human SLE monocytes which differed between CLs and NCLs. Conclusions In summary, single-cell gene expression in monocytes was associated with a wide range of clinical and biological features in SLE, providing much greater detail and insight into the cellular biology underlying the disease than previous mixed-cell population studies.
Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Rottenstreich, Amihai , Kalish, Yosef , Kleinstern, Geffen , Yaacov, Almog Ben, Dux, Joseph , Nissan, Aviram

Mayo Clinic

Journal of Surgical Oncology | June 26, 2017 | Volume: 116 | Issue: 7 | Pages: 914-920

10.1002/jso.24746 | PMID 28650573 Get It

Background and ObjectivesWe investigated the risk factors, incidence, and role of thromboprophylaxis in the development of thrombosis following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).MethodsWe reviewed data of patients with CRS/HIPEC in three hospitals.ResultsOverall, 192 patients underwent CRS/HIPEC during 2007‐2016. Mechanical (thigh‐length pneumatic compression stockings) and pharmacologic thromboprophylaxis (40 mg enoxaparin daily, starting 12 h before surgery until discharge) was provided for all patients; and 116 (60.4%) also received an extended course of enoxaparin for 2‐4 weeks after discharge. Twenty‐six patients experienced thrombotic complications (13.5%) including portal‐splenic‐mesenteric venous thrombosis (n = 11, 5.7%), pulmonary embolism (n = 10, 5.2%), and deep vein thrombosis (n = 5, 2.6%); most (n = 21, 80.8%) occurred after hospital discharge. Univariate analysis identified Peritoneal Cancer Index, intraoperative transfusion requirement, operative blood loss, operative time, lengths of hospital, and intensive care unit stay, and lack of administration of anticoagulation at discharge as significantly associated with thrombosis. With multivariate analysis, only the lack of anticoagulation therapy at discharge remained significantly associated with thrombosis (P = 0.0001).ConclusionsThromboembolic complications are common following CRS/HIPEC. As significantly lower rates of thrombosis were found in patients who received an extended course of anticoagulation, we support its use for at least 2 weeks after discharge.
Oxygen Consumption Deficits in Patients With Residual Fatigue After Primary Coccidioidomycosis
Ganley, Kathleen J., Bosch, Pamela R. , Blair, Janis E. , Rischard, Franz , Galgiani, John N. , Rischard, Franz P

Mayo Clinic

Open Forum Infectious Diseases | June 26, 2017 | Volume: 4 | Issue: 3 | Pages: No page available

10.1093/ofid/ofx136 | PMID 30591919 Get It

Abstract Patients with coccidioidomycosis often report prolonged and debilitating fatigue after other evidence of infection has resolved. In this study, we quantify fatigue, muscle weakness, and impaired aerobic capacity in 5 such individuals. A closer examination of the cardiorespiratory system may contribute to a better understanding of underlying mechanisms and potential interventions.
HHV‐6 in liver transplantation: A literature review
Phan, Tuan L. , Lautenschlager, Irmeli, Muñoz, Flor M. , Munoz, Flor M , Razonable, Raymund R.

Mayo Clinic

Liver International | June 26, 2017 | Volume: 38 | Issue: 2 | Pages: 210-223

10.1111/liv.13506 | PMID 28650593 Get It

AbstractHuman herpesvirus 6 (HHV‐6A and HHV‐6B) can cause primary infection or reactivate from latency in liver transplant recipients, which can result in a variety of clinical syndromes, including fever, hepatitis, encephalitis and higher rates of graft dysfunction as well as indirect effects including increased risks of mortality, CMV disease, hepatitis C progression and greater fibrosis scores. Although HHV‐6 infection is currently diagnosed by quantifying viral DNA in plasma or blood, biopsy to demonstrate histopathological effects of HHV‐6 remains the gold standard for diagnosis of end‐organ disease. HHV‐6 reactivation may be restricted to the infected organ with no evidence of active infection in the blood. HHV‐6 infections in liver transplant patients are mostly asymptomatic, but clinically significant tissue‐invasive infections have been treated successfully with ganciclovir, foscarnet or cidofovir. Inherited chromosomally integrated HHV‐6 (ciHHV‐6), in either the recipient or the donor organ, may create confusion about systemic HHV‐6 infection. Recipients with inherited ciHHV‐6 may have an increased risk of opportunistic infection and graft rejection. This article reviews the current scientific data on the clinical effects, risk factors, pathogenesis, diagnosis and treatment of HHV‐6 infections in liver transplant recipients.
The Null Effect of Bladder Neck Size on Incontinence Outcomes after Radical Prostatectomy
Tyson, Mark D. , Ark, Jacob , Gregg, Justin R. , Johnsen, Niels V. , Kappa, Stephen F., Lee, Daniel J. , Smith, Joseph A.

Mayo Clinic

Journal of Urology | June 24, 2017 | Volume: 198 | Issue: 6 | Pages: 1404-1408

10.1016/j.juro.2017.06.084 | PMID 28655528 Get It

Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?
Nofal, Alaa Al , Viers, Lyndsay D., Javed, Asma , Al Nofal, Alaa

Mayo Clinic

Gynecological Endocrinology | June 24, 2017 | Volume: 33 | Issue: 11 | Pages: 882-887

10.1080/09513590.2017.1342236 | PMID 28649885 Get It

Compound muscle action potential duration in critical illness neuromyopathy
Kramer, Christopher L., Boon, Andrea J. , Harper, C. Michel , Goodman, Brent P.

Mayo Clinic

Muscle & Nerve | June 24, 2017 | Volume: 57 | Issue: 3 | Pages: 395-400

10.1002/mus.25732 | PMID 28646510 Get It

ABSTRACTIntroductionWe sought to determine the specificity of compound muscle action potential (CMAP) durations and amplitudes in a large critical illness neuromyopathy (CINM) cohort relative to controls with other neuromuscular conditions.MethodsFifty‐eight patients with CINM who had been seen over a 17‐year period were retrospectively studied. Electrodiagnostic findings of the CINM cohort were compared with patients with axonal peripheral neuropathy and myopathy due to other causes.ResultsMean CMAP durations were prolonged, and mean CMAP amplitudes were severely reduced both proximally and distally in all nerves studied in the CINM cohort relative to the control groups. The specificity of prolonged CMAP durations for CINM approached 100% if they were encountered in more than 1 nerve.DiscussionProlonged, low‐amplitude CMAPs occur more frequently and with greater severity in CINM patients than in neuromuscular controls with myopathy and axonal neuropathy and are highly specific for the diagnosis of CINM. Muscle Nerve 57: 395–400, 2018
Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy‐organomegaly‐endocrinopathy‐monoclonal protein‐skin changes and chronic inflammatory demyelinating polyradiculoneuropathy
Wang, Wei , Litchy, William J. , Mauermann, Michelle L. , Dyck, P. James B. , Mandrekar, Jay , Klein, Christopher J. , Dispenzieri, Angela , Klein, Christopher J , Mauermann, Michelle L

Mayo Clinic

Muscle & Nerve | June 24, 2017 | Volume: 57 | Issue: 1 | Pages: No page available

10.1002/mus.25731 | PMID 28646568 Get It

ABSTRACTIntroduction: In polyradiculoneuropathy‐organomegaly‐endocrinopathy‐monoclonal protein‐skin changes (POEMS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), limb nerve conduction studies (NCSs) are limited in identifying demyelination and in detecting treatment effects in severely affected patients. Blink R1 latency may improve these assessments. Methods: POEMS and CIDP patients who had undergone NCS and blink reflex were identified. Correlations among R1 latency, limb NCS, and neuropathy impairment scores (NIS) were compared. Results: Among 182 patients (124 POEMS, 58 CIDP) who were identified, R1 prolongation (>13 ms) occurred in 64.3% (65.3% POEMS, 62.1% CIDP). R1 prolongation correlated with more severely affected NCS in both POEMS (ulnar CMAP 2.6 mV vs. 4.5 mV, P = 0.001) and CIDP (2.0 mV vs. 6.1 mV, P < 0.001). In severely affected patients (ulnar CMAP ≤0.5 mV [10%:18/182]), R1 (>13 ms) helped establish demyelination. In 31 patients (16 POEMS, 15 CIDP), the R1 latency changes were concordant with NIS changes in 94% of patients with POEMS and 60% of patients with CIDP. Discussion: Blink R1 latencies are valuable in defining demyelination and detecting improvement in severely affected POEMS and CIDP patients. Muscle Nerve 57: E8–E13, 2018
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
Hijazi, Ziad , Andersson, Ulrika , Lindbäck, Johan , Granger, Christopher B. , Alexander, John H. , Hanna, Michael G. , Harjola, Veli‐Pekka , Siegbahn, Agneta , Wallentin, Lars , Lindahl, Bertil , Oldgren, Jonas , Gersh, Bernard J. , Hylek, Elaine M. , Lópes, Renato D. , Lindbäck, Johan , Granger, Christopher B

Mayo Clinic

Journal of the American Heart Association | June 24, 2017 | Volume: 6 | Issue: 6 | Pages: No page available

10.1161/jaha.116.004851 | PMID 28645934 Get It

Background Cardiac biomarkers are independent risk markers in atrial fibrillation, and the novel biomarker–based ABC stroke score (age, biomarkers, and clinical history of prior stroke) was recently shown to improve the prediction of stroke risk in patients with atrial fibrillation. Our aim was to investigate the short‐term variability of the cardiac biomarkers and evaluate whether the ABC stroke risk score provides a stable short‐term risk estimate. Methods and Results According to the study protocol, samples were obtained at entry and also at 2 months in 4796 patients with atrial fibrillation followed for a median of 1.8 years in the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Cardiac troponin I, cardiac troponin T, and N‐terminal pro‐B‐type natriuretic peptide were measured with high‐sensitivity immunoassays. Associations with outcomes were evaluated by Cox regression. C indices and calibration plots were used to evaluate the ABC stroke score at 2 months. The average changes in biomarker levels during 2 months were small (median change cardiac troponin T +2.8%, troponin I +2.0%, and N‐terminal pro‐B‐type natriuretic peptide +13.5%) and within‐subject correlation was high (all ≥0.82). Repeated measurement of cardiac biomarkers provided some incremental prognostic value for mortality but not for stroke when combined with clinical risk factors and baseline levels of the biomarkers. Based on 8702 person‐years of follow‐up and 96 stroke/systemic embolic events, the ABC stroke score at 2 months achieved a similar C index of 0.70 (95% CI, 0.65–0.76) as compared with 0.70 (95% CI, 0.65–0.75) at baseline. The ABC stroke score remained well calibrated using predefined risk classes. Conclusions In patients with stable atrial fibrillation, the variability of the cardiac biomarkers and the biomarker‐based ABC stroke score during 2 months are small. The prognostic information by the ABC stroke score remains consistent and well calibrated with similar good predictive performance if patients are retested after 2 months. Clinical Trial Registration URL: http://www.clinicaltrials.gov . Unique identifier: NCT 00412984.